Latest News about GSK
Recent news which mentions GSK
FDA Approves GSK's Oral Antibiotic For Urinary Tract Infections For Females Aged 12 Years And Older
March 26, 2025
From Benzinga
From Benzinga
Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides
March 19, 2025
From Benzinga
From Benzinga
Cancer-Focused Zymeworks' Q4 Earnings Miss Expectations, Reprioritize Resources To Focus On ZW251
March 06, 2025
From Benzinga
GSK's Once-Daily Inhalers For Smoker's Lung Has Potential Benefits: Independent Organization Report
March 04, 2025
From Benzinga
From Benzinga
Amgen-AstraZeneca Partnered Asthma Drug Shows Rapid And Sustained Effect In Chronic Rhinosinusitis
March 03, 2025
From Benzinga
Sensodyne Toothpaste Maker Haleon Expects Profit To Be Weighted Towards Second Half Of 2025
February 27, 2025
From Benzinga
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
February 18, 2025
From Benzinga
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
February 17, 2025
From Benzinga
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
February 11, 2025
From Benzinga
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch
February 10, 2025
From Benzinga
Electronic Arts Posts Upbeat Earnings, Joins Mattel, Johnson Controls, Mueller Water Products And Other Big Stocks Moving Higher On Wednesday
February 05, 2025
From Benzinga
GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion
February 05, 2025
From Benzinga
Earnings Scheduled For February 5, 2025
February 05, 2025
From Benzinga
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm?
January 28, 2025
From Benzinga
Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads
January 24, 2025
From Benzinga
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine
January 21, 2025
From Benzinga
Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer
January 21, 2025
From Benzinga
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt
January 17, 2025
From Benzinga
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
January 17, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Why CureVac (CVAC) Shares Are Volatile
January 10, 2025
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.